Overview
Whether or not the United States has safe and effective medical countermeasures—such as vaccines, drugs, and diagnostic tools—available for use during a disaster can mean the difference between life and death for many Americans. The Food and Drug Administration (FDA) and the scientific community at large could benefit from improved scientific tools and analytic techniques to undertake the complex scientific evaluation and decision making needed to make essential medical countermeasures available. At the request of FDA, the Institute of Medicine (IOM) held a workshop to examine methods to improve the development, evaluation, approval, and regulation of medical countermeasures. During public health emergencies such as influenza or chemical, biological, radiological/nuclear (CBRN) attacks, safe and effective vaccines, treatments, and other medical countermeasures are essential to protecting national security and the well being of the public. Advancing Regulatory Science for Medical Countermeasure Development examines current medical countermeasures, and investigates the future of research and development in this area. Convened on March 29-30, 2011, this workshop identified regulatory science tools and methods that are available or under development, as well as major gaps in currently available regulatory science tools. Advancing Regulatory Science for Medical Countermeasure Development is a valuable resource for federal agencies including the Food and Drug Administration (FDA), the Department of Health and Human Services (HHS), the Department of Defense (DoD), as well as health professionals, and public and private health organizations. Table of Contents Front Matter 1 Introduction 2 MCM Enterprise and Stakeholder Perspectives 3 Cutting-Edge Efforts to Advance MCM Regulatory Science 4 MCM Regulatory Science Needs for At-Risk Populations 5 Crosscutting Themes and Future Directions 6 Closing Remarks References Appendix A: Workshop Agenda Appendix B: Participant Biographies
Full Product Details
Author: Institute of Medicine ,
Board on Health Sciences Policy ,
Forum on Medical and Public Health Preparedness for Catastrophic Events ,
Forum on Drug Discovery, Development, and Translation
Publisher: National Academies Press
Imprint: National Academies Press
Dimensions:
Width: 15.20cm
, Height: 1.00cm
, Length: 22.90cm
Weight: 0.272kg
ISBN: 9780309214902
ISBN 10: 0309214904
Pages: 150
Publication Date: 27 August 2011
Audience:
Professional and scholarly
,
Professional & Vocational
Format: Paperback
Publisher's Status: Active
Availability: In Print
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.
